This inventor holds 5 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Novartis Ag, Novartis Pharma Ag. Active years: 2012-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Perchtoldsdorf, AT (2012 - 2016)
- Oberwill, CH (2016 - 2021)
Company Filing History:
Years Active: 2012-2021
Title: Maximilian Woisetschlaeger: Innovator in Antibody Formulations
Introduction
Maximilian Woisetschlaeger is a notable inventor based in Perchtoldsdorf, Austria. He has made significant contributions to the field of biotechnology, particularly in the development of antibody formulations. With a total of five patents to his name, Woisetschlaeger has demonstrated a commitment to advancing medical science.
Latest Patents
Woisetschlaeger's latest patents focus on Anti-BAFFR antibody formulations and methods of use. These formulations are designed as either lyophilisates or liquid formulations. The lyophilisates can be reconstituted to create a solution with a high concentration of the antibody active ingredient, allowing for effective delivery to patients without high levels of antibody aggregation. The reconstitution process can yield an aqueous composition with an antibody concentration of at least 50 mg/ml. Additionally, the formulations may include various components such as sugars, buffering agents, surfactants, and free amino acids to enhance their efficacy.
Career Highlights
Throughout his career, Woisetschlaeger has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma AG. His experience in these organizations has provided him with a solid foundation in research and development, particularly in the area of antibody therapies.
Collaborations
Wois
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile